Detalles de la búsqueda
1.
Impact of Anti-HER2 Therapy Alone and With Weekly Paclitaxel on the Ovarian Reserve of Young Women With HER2-Positive Breast Cancer.
J Natl Compr Canc Netw
; 21(1): 33-41.e16, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36634607
2.
Diffusion MRI signal cumulants and hepatocyte microstructure at fixed diffusion time: Insights from simulations, 9.4T imaging, and histology.
Magn Reson Med
; 88(1): 365-379, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35181943
3.
A Comprehensive Biomarker Analysis of Microsatellite Unstable/Mismatch Repair Deficient Colorectal Cancer Cohort Treated with Immunotherapy.
Int J Mol Sci
; 24(1)2022 Dec 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36613564
4.
Genetic evolution to tyrosine kinase inhibitory therapy in patients with EGFR-mutated non-small-cell lung cancer.
Br J Cancer
; 125(11): 1561-1569, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34599295
5.
PI3K activation promotes resistance to eribulin in HER2-negative breast cancer.
Br J Cancer
; 124(9): 1581-1591, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33723394
6.
A CT-based Radiomics Signature Is Associated with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors.
Radiology
; 299(1): 109-119, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33497314
7.
Tumor-Associated Microbiome: Where Do We Stand?
Int J Mol Sci
; 22(3)2021 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33535583
8.
Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuvant Therapy.
Int J Mol Sci
; 21(4)2020 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32085669
9.
Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Oncol
; 20(9): 1226-1238, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31402321
10.
Everolimus plus Exemestane for Hormone Receptor-Positive Advanced Breast Cancer: A PAM50 Intrinsic Subtype Analysis of BOLERO-2.
Oncologist
; 24(7): 893-900, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30679318
11.
Analysis of the PD-1/PD-L1 axis in human autoimmune thyroid disease: Insights into pathogenesis and clues to immunotherapy associated thyroid autoimmunity.
J Autoimmun
; 103: 102285, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31182340
12.
HER2-enriched subtype as a predictor of pathological complete response following trastuzumab and lapatinib without chemotherapy in early-stage HER2-positive breast cancer (PAMELA): an open-label, single-group, multicentre, phase 2 trial.
Lancet Oncol
; 18(4): 545-554, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28238593
13.
Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research.
Adv Anat Pathol
; 24(5): 235-251, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28777142
14.
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.
Adv Anat Pathol
; 24(6): 311-335, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28777143
15.
Quantification of HER family receptors in breast cancer.
Breast Cancer Res
; 17: 53, 2015 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-25887735
16.
NUMB controls p53 tumour suppressor activity.
Nature
; 451(7174): 76-80, 2008 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-18172499
17.
A whirl of radiomics-based biomarkers in cancer immunotherapy, why is large scale validation still lacking?
NPJ Precis Oncol
; 8(1): 42, 2024 Feb 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38383736
18.
Identification of Precise 3D CT Radiomics for Habitat Computation by Machine Learning in Cancer.
Radiol Artif Intell
; 6(2): e230118, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38294307
19.
Weakly Supervised Deep Learning Predicts Immunotherapy Response in Solid Tumors Based on PD-L1 Expression.
Cancer Res Commun
; 4(1): 92-102, 2024 01 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38126740
20.
LOXL2-mediated chromatin compaction is required to maintain the oncogenic properties of triple-negative breast cancer cells.
FEBS J
; 2024 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38451841